dihydroxyphenylalanine has been researched along with rotenone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, Y; Nagatsu, T | 1 |
| Abd El-Rehim, HA; El-Ghazaly, MA; Rashed, ER | 1 |
| Guo, Q; Liu, Z; Smith, WW; Wang, B; Wang, X; Zhu, Y | 1 |
3 other study(ies) available for dihydroxyphenylalanine and rotenone
| Article | Year |
|---|---|
Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slices.
Topics: Adenosine Triphosphate; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Survival; Corpus Striatum; Dihydroxyphenylalanine; Hydroxylation; Male; Organ Culture Techniques; PC12 Cells; Rats; Rats, Wistar; Rotenone; Tyrosine | 2005 |
Potential efficacy of dopamine loaded-PVP/PAA nanogel in experimental models of Parkinsonism: possible disease modifying activity.
Topics: Acrylic Resins; Animals; Catalepsy; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Male; Nanogels; Parkinsonian Disorders; Polyethylene Glycols; Polyethyleneimine; Povidone; Rats, Wistar; Rotenone; Spectroscopy, Fourier Transform Infrared; Treatment Outcome | 2015 |
Activation of Nrf2 in Astrocytes Suppressed PD-Like Phenotypes via Antioxidant and Autophagy Pathways in Rat and Drosophila Models.
Topics: Adenine; Animals; Animals, Genetically Modified; Antioxidants; Antiparkinson Agents; Astrocytes; Autophagy; Behavior, Animal; Dihydroxyphenylalanine; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Male; Motor Activity; Nerve Degeneration; NF-E2-Related Factor 2; Oleanolic Acid; Parkinsonian Disorders; Phenotype; Rats, Sprague-Dawley; Repressor Proteins; Rotenone; Signal Transduction; Sirolimus | 2021 |